Medipharm Labs Corp T.LABS

So what is next week PR?

[TreborTheGreat]

Earnings?

FDA Review?

Partner?

[mdjbrown]

TTG you can guarantee it wont be earnings, as Q3 fins are not due until mid November and my guess is it might be a while before Medipharms partner is ready to be announced. As far as the FDA goes, it is anyones guess what will come of the Epidiolex patent challeges, but if Medipharms partner is on the right side of the decision, it should be golden for Labs. Interesting that the current book

[Starkicker]

I'd be interested to know if their revenue in Germany has been growing with their partnerships with ADREXpharma and STADA. They've been there for at least a couple of years now but I can't find any isolated German revenue numbers. 

[alleyesonme]

https://www.reuters.com/world/europe/german-cabinet-agrees-bill-legalizing-recreational-cannabis-use-2023-08-16/ Additionally https://mjbizdaily.com/germanys-cannabis-insurance-payouts-hit-51-million-euros-in-1st-quarter/#:~:text=Insurance%20reimbursements%20for%20medical%20cannabinoid,the%20largest%20in%20the%20world.  You may recall discussion last CC W.R.T EU GMP certified flower

[Starkicker]

Thanks Alleyes. Germany had to scale back its cannabis legislation due to pressure from other EU members re the Single Convention on Narcotic Drugs. If that convention was updated to remove cannabis, it would open up all kinds of markets and profit margins. Slow progress but moving in the right direction. Cheers, SK.

[alleyesonme]

Under reported, medical side has been strengthened.https://www.biospace.com/article/medical-first-germany-strengthens-reimbursement-of-medical-cannabis/

[mdjbrown]

Star, here is as much as is available for recent international sales in 2023 In the first quarter ended March 31, 2023 International medical cannabis sales amounted to CA$1.8 million, up from CA$1.3 million in the first quarter last year. CA$51,000 in Australia. CA$1.2 million in Germany. CA$575,000 in other, unspecified places. Followed by a huge jump in

[Starkicker]

Thanks, MDJ, very much appreciated. The year over year increase from Q2 2022 to Q2 2023 looks promising (249% increase) for Q2 2024.  Germany has about 130,000 registered users as of 2021 so it looks like the number of patients there is increasing steadily.  Was just using rhat data to gauge what we can expect from Brazil. We can probably expect a start in the $1-2M range.  Pretty

[mdjbrown]

You are very welcome Starkicker. I agree that the numbers are small in comparison, but keep in mind all of these medical CBD markets are in their infancy, and as these markets continue to grow yoy, so will Medipharms revenues in each region. For example, in Germany they say only 2% of doctors prescribe CBD as a medical alternative largely due to confusion, lack of knowledge or education around